Erythromycin poudrage vs erythromycin slurry in the treatment of refractory spontaneous pneumothorax
Journal of Thoracic Disease Feb 22, 2018
Zhai CC, et al. - In this current investigation, researchers compared thoracoscopic erythromycin poudrage with erythromycin slurry via a chest tube for patients with documented refractory spontaneous pneumothorax (RSP). Findings demonstrated the efficacy as well as safety of erythromycin as a sclerosing agent for pleurodesis in management of RSP. Although both of these methods were found to be safe, erythromycin poudrage was more effective than erythromycin slurry.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries